It was an illuminating moment, not just an amusing line. Every new administration has factions that end up hating one another despite being on the same official team. But the second Trump White House ...

In a groundbreaking announcement, former President Donald Trump has unveiled an ambitious $500 billion plan aimed at pioneering a cancer vaccine that could change the landscape of treatment for ...

RNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why Goldman ...

In 2025, the AI landscape is undergoing a transformative shift, expanding into two critical new layers: the application layer ...

The article continued: Recently Spotify's founder Daniel Ek's new HealthTech startup Neko Health secured a $260 million financing, valuing the company at approximately $1.8 billion. As part of the ...

One day after being sworn in as the 47th president of the United States, Donald Trump revealed the creation of Stargate, a ...

A scene from the first week of the second Trump administration: After the president held a White House event announcing a ...

“Successful self-replication under no human assistance is the essential step for AI to outsmart [humans], and is an early ...

Evercore ISI lowered the firm’s price target on Moderna (MRNA) to $50 from $60 and keeps an In Line rating on the shares. The firm is updating ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

President Trump's $500 billion Stargate Initiative to build AI infrastructure faces blowback from his conspiracist supporters ...

Stargate CEOs cite project’s promise of enabling cancer vaccines, though Musk joins critics in questioning partners’ financial strength and wisdom of the joint venture.